News

On April 8th, 2019 from 8:30 am to 5 pm the FDA will hold a public workshop entitled “Development of Antibacterial Drugs for the Treatment of Nontuberculous Mycobacterial Disease.” The purpose of the public workshop is to discuss the clinical trial design considerations, including endpoints,...
Read More
On April 8th, 2019 the U.S. Food & Drug Administration will host a public workshop on the development of antibacterial drugs for the treatment of nontuberculous mycobacterial (NTM) infection. At this workshop, we will convey patient experiences and preferences. Ahead of the workshop, we have...
Read More
Registration is now open for the 2019 Physician/Patient Conference!
Read More